21
AASMMembershipSectionsNewsletter
■
Issue #5
Pr Dauvilliers is amember of the
scientific board of theFrenchSleep
MedicineandResearchSociety,
amember of theEuropeanSleep
ResearchSociety, International
REM sleepbehaviour study group,
andmore recently of theAmerican
Academy of SleepMedicine. He is
theDirector of theSleepDisorders
Centre, Department of Neurology,
Gui deChauliacHospital, Montpellier
since2005, amember of theClinical
ResearchDepartment, University
Hospital, Montpellier since2000,
associate coordinator of theGui-
de-ChauliacUniversityHospital,
Montpellier-France, since2012and
Member of theEditorial Board of
SleepMedicine andSleep.
AlanHoffman, MD
Dr. Hoffman is aVancouver Is-
land-basedSleepDisordersConsul-
tant, andMedical Director of Med-
SleepVancouver Island (including
theNanaimoSleepClinic), and a
consultant SleepRespirologist at
MedSleepCalgary and theNorthern
AlbertaSleepClinic, with a back-
ground in Internal Medicine, Critical
Care andChest Medicine. He is
a frequent lecturer ona variety of
sleepmedicine related topics, is a
Medical Surveyor for theDiagnostic
AccreditationProgram of BC, and an
Adjunct Professor at ThompsonRiv-
ersUniversity inKamloops. Hehas
practiced inmany locales including
theUSA, MiddleEast and theUK,
aswell as in several Provinces. He
started out in the late1960’s as a
hospital based respiratory therapist,
thenbecame abiochemist, eventual-
ly runninghis own lipid biochemistry
andmass spectroscopy laboratory
at theNational Institutes of Health
inBethesda, as aFogartyVisiting
Scientist. His clinical practice and
focus now is devoted to the science
andmedicineof sleepdisorders. He
liveswith hiswife inMapleBay in the
Cowichan valley, where they have a
photography studio, custompicture
framingworkshopandart gallery. ■
Tuesday, June3rd
Meet theProfessor
M14:Treatment ofNarcolepsy
12:30pm–1:30pm
Thomas Scammell,MD
NarcolepsySectionMeeting
5:15pm–6:15pm
RichardP. Knudsen,MD (Updates in
theneuroimmunologyof narcolepsy);
YvesDauvilliers,MD, PhD (Recentmajor
discoveries in thepharmacotherapy for
narcolepsy);AlanHoffman,MD, PhD
(Comorbid anxiety/mooddisorders in
Narcolepsy, Rx– related as a confounder);
andCarmelaGonzales,MD (Young
InvestigatorAward:Theutilityof the
sustained sleep latencyonPSG and the
MSLT in thediagnosis of patientswith
hypersomniaof central origin)
Wednesday, June4th
Symposia
S17:What isCataplexy?
8:00am–10:00am
Meet theProfessor
M21:How toEvaluateandManageEDS in
Childhood
12:30pm–1:30pm
SureshKotagal,MBBS
Oral Presentation
027:NarcolepsyandHypersomnias
RelatedPsychiatricDisease
1:30pm–2:30pm
ClinicalWorkshop
W07:HypersomniaandNarcolepsy in the
PediatricPopulation
2:45pm–4:45pm
The secondportionof our contribution
centers on amajor breakthrough in the
fieldof narcolepsy research.Vigorous
commendation is sent out toDr. Emmanuel
Mignot,Director, SleepSciences and
Medicine, StanfordUniversity, for his
recent discoveryof the locus of the epitope
(autoantigen) toward induction-onset
autoimmunenarcolepsy.This scientific
breakthroughwill likely lead to an ‘invitro’
test,whichwill enable clinicians to earlier
andmore accuratelydetect dysimmune
narcolepsy,with the addedbenefit of
swifter immunomodulatory intervention
and consequent sparingof thedepthof
profound, chronicdisease.
ForAASMmembers interested in
reviewing the actual reference, please refer
to:
De laHerran-AritaAK, Kornum
BR,Mahlios J, et al. CD4+T cell
autoimmunity tohypocretin/orexin
and cross-reactivity to a2009H1N1
influenzaA epitope innarcolepsy.
ScienceTranslMed2013;5(216ra176).
/
content/5/216/216ra176.full.
pdf?sid=769b592b-4eb8-4b42-be80-
b9ee3b6c6db8
RichardPKnudsen,MD
Chair,
Narcolepsy
